CQ Liang, YM Li - Current Opinion in Chemical Biology, 2021 - Elsevier
Amyloid proteins can aggregate into insoluble fibrils and form amyloid deposits in the human brain, which is the hallmark of many neurodegenerative diseases. Promising …
M Qafary, F Rashno, K Khajeh, M Khaledi… - Progress in Biophysics …, 2022 - Elsevier
Insulin and its homologous are the most utilized protein drugs due to their role in diabetic patients' treatment. Insulin forms amyloid-like fibrils in vivo at the injection site. Therefore, the …
W Puławski, R Dec, W Dzwolak - Molecular Pharmaceutics, 2024 - ACS Publications
Insulin aggregation poses a significant problem in pharmacology and medicine as it occurs during prolonged storage of the hormone and in vivo at insulin injection sites. We have …
N Majid, RH Khan - International Journal of Biological Macromolecules, 2023 - Elsevier
Proteins play a major role in the regulation of various cellular functions including the synthesis of structural components. But proteins are stable under physiological conditions …
In recent years, due to the aging of the population and the development of diagnostic medicine, the number of identified diseases associated with the accumulation of amyloid …
S Malik, MK Siddiqi, N Naseem, F Nabi, A Masroor… - Biochimie, 2023 - Elsevier
Protein aggregation is an underlying cause of many neurodegenerative diseases. Also, the overlapping pathological disturbances between neurodegenerative diseases and type-2 …
The aggregation of Aβ42 is established as a key factor in the development of Alzheimer's disease (AD). Consequently, molecules that inhibit aggregation of peptide may lead to …
Insulin fibrillation is a problem for diabetic patients that can occur during storage and transport, as well as at the subcutaneous injection site, with loss of bioactivity, inflammation …
We have synthesized biocompatible ionic liquids (ILs) with choline as cation and amino acids as anions to explore their potential towards prevention of fibrillation in insulin and the …